Resources
News

Verrill Dana Welcomes Health Care Attorney Cecilie MacIntyre

December 13, 2016 Press Releases

(December 13, 2016) – Verrill Dana is pleased to welcome Cecilie MacIntyre to the firm's growing Health Care Group as Counsel in its Portland, Maine office.

Prior to returning to private practice, MacIntyre served as an Assistant Chief Counsel at the California Department of Managed Health Care. In her role at the Department, she addressed an array of legal and policy issues, such as health insurer mergers and the regulation of Accountable Care Organizations and provider groups, as well as issues arising from the Patient Protection and Affordable Care Act. She also helped implement and administer laws regarding managed care organizations. As a former Associate in the Litigation Department of Dorsey and Whitney's New York office, MacIntyre has also worked on a range of different issues, including intellectual property disputes, insurance defense cases, and white collar criminal matters.

MacIntyre is a graduate of the University of Chicago and received her law degree from Cornell Law School.

The addition of MacIntyre to the firm comes less than six months after fellow attorneys Katherine Chaurette and Sarah Trautz joined Verrill Dana's Health Care Group in its Boston, Massachusetts office. The growth of the Group is in response to increased legal demand in the Health Care industry, including the medical devices, pharmaceuticals, and bioscience fields.

About Verrill Dana's Health Care Group: Verrill Dana's Health Care Group serves a wide variety of organizations in the healthcare industry and related professions with respect to a wide range of matters including academic and biomedical research, accountable care organizations and managed care, eHealth and health information technology, HIPAA/HITECH privacy and security, Medicare/Medicaid and third-party reimbursement, mergers and acquisitions, and regulatory compliance. Learn more about the group at www.verrilldana.com/healthcare.

Firm Highlights

Matter

European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...

Publication/Podcast

FDA Issues Guidance on IRB Review of Non-Emergency Individual Patient Expanded Access Requests for Investigational Drugs and Biological Products to Treat COVID-19

Prompted by a substantial increase in requests for individual patient access to investigational drugs and biologics to treat COVID-19, the U.S. Food & Drug Administration (“FDA”) issued guidance on June 2, 2020 that outlines...

Matter

Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.

Matter

Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.

Publication/Podcast

News Flash: HHS Issues Statement Removing Premarket Review Requirements for Laboratory Developed Tests (“LDTs”), Including COVID-19 LDTs

What happened? On August 19, 2020, the U.S. Department of Health and Human Services (“HHS”) issued a single paragraph statement rescinding U.S. Food and Drug Administration (“FDA”) guidance documents concerning premarket review of Laboratory...

Publication/Podcast

FDA Updates its Guidance on Conducting Clinical Trials During COVID-19 Public Health Emergency

On April 16, 2020, the U.S. Food & Drug Administration (“FDA”) again updated its guidance on the “Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency,” adding seven new questions and...

Publication/Podcast

EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...

News

Nearly 80 Verrill Attorneys Recognized by Best Lawyers® 2021, Including a Dozen Named Lawyers of the Year

(August 24, 2020) – Nearly 80 Verrill attorneys were recognized as "Best Lawyers" by Best Lawyers® 2021 , including 12 attorneys named “Lawyer of the Year,” a distinguished recognition for only a single lawyer...

Matter

Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...

News

Michael K. Fee to Lead Verrill’s Nationally-Recognized Health Care and Life Sciences Practice Amidst Recent Changes

(August 31, 2020) – Verrill is pleased to announce Michael K. Fee as the new leader of Verrill’s nationally-recognized Health Care & Life Sciences Group. The Group has a long history of representing a...